Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A, Meucci G, Gasbarrini A, Guidi L, Lavagna A, Sostegni R, Onali S, Papi C, Kohn A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Monterubbianesi R, et al. Among authors: lavagna a. J Crohns Colitis. 2014 Aug;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25. J Crohns Colitis. 2014. PMID: 24472490
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.
Vitello A, Grova M, Pugliese D, Rizzello F, Lanzarotto F, Lavagna A, Caccaro R, Cappello M, Viola A, Ribaldone DG, Principi M, Stasi E, Scribano ML, Maida M, Soriano A, Bezzio C, Bodini G, Mocciaro F, Privitera AC, Simondi D, Giuffrida E, D'Incà R, Ricci C, Gionchetti P, Armuzzi A, Orlando A, Daperno M; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Vitello A, et al. Among authors: lavagna a. Dig Liver Dis. 2022 Mar;54(3):352-357. doi: 10.1016/j.dld.2021.08.020. Epub 2021 Sep 17. Dig Liver Dis. 2022. PMID: 34538764
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
Orlando A, Colombo E, Kohn A, Biancone L, Rizzello F, Viscido A, Sostegni R, Benazzato L, Castiglione F, Papi C, Meucci G, Riegler G, Mocciaro F, Cassinotti A, Cosintino R, Geremia A, Morselli C, Angelucci E, Lavagna A, Rispo A, Bossa F, Scimeca D, Cottone M; Italian Multicentric Study Group on Infliximab. Orlando A, et al. Among authors: lavagna a. Dig Liver Dis. 2005 Aug;37(8):577-83. doi: 10.1016/j.dld.2005.01.019. Dig Liver Dis. 2005. PMID: 15886081 Clinical Trial.
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M, Sostegni R, Canaparo R, Serpe L, Lavagna A, Crocellà L, Castagno F, Vernetto A, Rigazio C, Ercole E, D'Antico S, Pera A, Zara G, Rocca R. Daperno M, et al. Among authors: lavagna a. Aliment Pharmacol Ther. 2009 Oct 15;30(8):843-53. doi: 10.1111/j.1365-2036.2009.04106.x. Epub 2009 Jul 24. Aliment Pharmacol Ther. 2009. PMID: 19650826
37 results